YU44774B - Process for obtaining 2-(1h)-hynolon - Google Patents

Process for obtaining 2-(1h)-hynolon

Info

Publication number
YU44774B
YU44774B YU889/85A YU88985A YU44774B YU 44774 B YU44774 B YU 44774B YU 889/85 A YU889/85 A YU 889/85A YU 88985 A YU88985 A YU 88985A YU 44774 B YU44774 B YU 44774B
Authority
YU
Yugoslavia
Prior art keywords
hynolon
obtaining
Prior art date
Application number
YU889/85A
Other languages
English (en)
Other versions
YU88985A (en
Inventor
D A Roberts
S F Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848413685A external-priority patent/GB8413685D0/en
Priority claimed from GB848427167A external-priority patent/GB8427167D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of YU88985A publication Critical patent/YU88985A/xx
Publication of YU44774B publication Critical patent/YU44774B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
YU889/85A 1984-05-29 1985-05-28 Process for obtaining 2-(1h)-hynolon YU44774B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848413685A GB8413685D0 (en) 1984-05-29 1984-05-29 Quinolone inotropic agents
GB848427167A GB8427167D0 (en) 1984-10-26 1984-10-26 Quinoline inotropic agents

Publications (2)

Publication Number Publication Date
YU88985A YU88985A (en) 1987-12-31
YU44774B true YU44774B (en) 1991-02-28

Family

ID=26287793

Family Applications (1)

Application Number Title Priority Date Filing Date
YU889/85A YU44774B (en) 1984-05-29 1985-05-28 Process for obtaining 2-(1h)-hynolon

Country Status (18)

Country Link
US (3) US4728653A (xx)
EP (1) EP0166533B1 (xx)
KR (1) KR870001167B1 (xx)
AU (1) AU562081B2 (xx)
CA (1) CA1292234C (xx)
DE (1) DE3577091D1 (xx)
DK (1) DK236085A (xx)
EG (1) EG17344A (xx)
ES (1) ES8608874A1 (xx)
FI (1) FI852123L (xx)
GR (1) GR851296B (xx)
HU (1) HU195961B (xx)
IL (1) IL75326A (xx)
NO (1) NO163186B (xx)
NZ (1) NZ212209A (xx)
PL (1) PL145325B1 (xx)
PT (1) PT80533B (xx)
YU (1) YU44774B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735948A (en) * 1983-03-25 1988-04-05 Merrell Dow Pharmaceuticals Inc. (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
ZA859091B (en) * 1984-12-24 1987-07-29 Warner Lambert Co Novel 6-substituted-2 (1h)-quinolinones and related compounds having use as cardiotonic,anti-hypertensive,and anti-thrombotic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
US4792561A (en) * 1986-05-29 1988-12-20 Syntex (U.S.A.) Inc. Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors
GB8619902D0 (en) * 1986-08-15 1986-09-24 Pfizer Ltd Quinolone cardiac stimulants
GB8630702D0 (en) * 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
DE3819565A1 (de) * 1988-06-09 1990-04-12 Hoechst Ag Verfahren zur herstellung von 4-nitro-3-trifluormethyl-anilin
US5223525A (en) * 1989-05-05 1993-06-29 Rhone-Poulenc Ag Company Pesticidal 1-arylimidazoles
CZ284824B6 (cs) * 1989-05-05 1999-03-17 Rhone-Poulenc Agrochimie 1-Arylimidazoly, způsob jejich výroby a meziprodukty v tomto způsobu, prostředky, které je obsahují a jejich použití
KR0164842B1 (ko) * 1990-03-24 1999-01-15 손정삼 신규 벤즈옥사진, 벤조티아진 유도체 및 그 제조방법
US5200419A (en) * 1990-05-21 1993-04-06 Warner-Lambert Company Substituted tetrazoles and derivatives thereof acting at muscarinic receptors
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
AU751139B2 (en) * 1997-10-13 2002-08-08 Astellas Pharma Inc. Amide derivative
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
JP2003508402A (ja) * 1999-08-27 2003-03-04 リガンド・ファーマシューティカルズ・インコーポレイテッド アンドロゲン受容体モジュレーター化合物および方法
CO5200852A1 (es) 1999-09-14 2002-09-27 Lilly Co Eli Moduladores rxr con mejorado perfil farmacologico ceptores x de los retinoides
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US6660864B2 (en) * 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2003002529A2 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6596871B2 (en) * 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) * 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
WO2003002121A1 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
WO2003002120A1 (en) * 2001-06-29 2003-01-09 Aaipharma, Inc. Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
US6657061B2 (en) * 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
MXPA06001751A (es) * 2003-08-22 2006-05-12 Ligand Pharm Inc Derivados de 6-cicloamino-2-quinolinona como compuestos moduladores de receptor de androgeno.
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
AU2013205820B2 (en) * 2005-06-09 2015-11-26 Novartis Ag Process for the synthesis of organic compounds
PL2508523T5 (pl) * 2007-10-23 2020-08-10 Teva Pharmaceutical Industries Ltd. Odmiany polimorficzne dasatynibu i sposób ich wytwarzania
CN111278816B (zh) * 2017-09-04 2024-03-15 C4医药公司 二氢喹啉酮

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
JPS5473783A (en) * 1977-11-15 1979-06-13 Otsuka Pharmaceut Co Ltd Pyridine derivative
DE2815956A1 (de) * 1978-04-13 1979-10-18 Bayer Ag Verfahren zur herstellung von in 2-stellung substituierten triazolen-1,2,3
JPS5535019A (en) * 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
JPS5576872A (en) * 1978-12-06 1980-06-10 Yoshitomi Pharmaceut Ind Ltd Imidazolidinone derivative
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
US4432979A (en) * 1981-10-26 1984-02-21 William H. Rorer, Inc. Pyridone compounds
EP0102046A1 (en) * 1982-08-26 1984-03-07 Schering Corporation Tricyclic lactams, method for making them, pharmaceutical compositions containing them
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
US4591591A (en) * 1984-03-08 1986-05-27 Eli Lilly And Company Pyridazinone derivatives as inotropic agents

Also Published As

Publication number Publication date
FI852123L (fi) 1985-11-30
EP0166533A1 (en) 1986-01-02
US4837334A (en) 1989-06-06
DK236085A (da) 1985-11-30
ES8608874A1 (es) 1986-09-01
US4728653A (en) 1988-03-01
NZ212209A (en) 1988-08-30
PT80533A (en) 1985-06-01
HUT40642A (en) 1987-01-28
FI852123A0 (fi) 1985-05-28
IL75326A (en) 1988-09-30
DE3577091D1 (en) 1990-05-17
EP0166533B1 (en) 1990-04-11
ES543514A0 (es) 1986-09-01
HU195961B (en) 1988-08-29
GR851296B (xx) 1985-11-25
US4900839A (en) 1990-02-13
PL145325B1 (en) 1988-09-30
KR870001167B1 (ko) 1987-06-15
DK236085D0 (da) 1985-05-28
KR850008675A (ko) 1985-12-21
PL253689A1 (en) 1986-07-01
IL75326A0 (en) 1985-09-29
YU88985A (en) 1987-12-31
NO852124L (no) 1985-12-02
EG17344A (en) 1991-08-30
AU562081B2 (en) 1987-05-28
AU4303285A (en) 1985-12-05
NO163186B (no) 1990-01-08
CA1292234C (en) 1991-11-19
PT80533B (en) 1987-04-06

Similar Documents

Publication Publication Date Title
YU44774B (en) Process for obtaining 2-(1h)-hynolon
YU114587A (en) Process for obtaining new 2-(n-substituted-guanidine)-4-heteroarylthiazole
YU107285A (en) Process for obtaining new gangliozidic derivatives
YU126787A (en) Process for obtaining 9a-aza-9a-homoeritromicyn derivatives
PT75506B (en) Process for the preparation of 2-(1h)-piridinones
YU55685A (en) Process for obtaining hydroxi-4-2h-1-benzothiopyran-2 one
ZA824618B (en) Process for preparing 2-(thienyl-2)-ethylamines and 2-(thienyl-3)-ethylamines
YU43869B (en) Process for obtaining of 2-oxyndol-1-carboxamide
YU69785A (en) Process for obtaining l-carnityne
HUT38952A (en) Process for 16alpha-metylation
ZA852603B (en) 2-(alkoximinoalkoxycarbonyl)-phenylsulphonylureas
HUT38633A (en) Process for preparing 2-guanidine-4-/2-methyl-4-imidazolyl/-thiazole-dihydrobromide
GB2183670B (en) Process for self-hydrogenation
GB2159154B (en) Methyl 2-(2-hydroperoxy-2-propyl)naphthalene-6-carboxylate
IL76367A0 (en) Improved process for cephalsporin intermediates
YU6185A (en) Process for obtaining phenoxi-benzaldeniodic derivatives
YU102587A (en) Process for obtaining substituted ethandiimidamides
DE3563448D1 (en) Process for preparing polyphenylenethers
YU73085A (en) Process for obtaining 2-oxindole-1-carboxamide compound
YU53085A (en) Process for obtaining eburhanic derivatives
GB2163157B (en) Process for hydroxyarylaldehydes
DE3560712D1 (en) Process for preparing chloroolefins
DE3560394D1 (en) Process for preparing 1-amino-2-bromo-4-hydroxy-anthraquinone
YU149985A (en) Process for obtaining 5,6-dialcoxi-4-alkyl-2(1h)-hinazolinone
YU43698B (en) Process for obtaining 3-acetoximethyl-7-/2-(2-aminothiazolyl-4)-2-syn-metoxiimino)-acetamide-3-cephem-carboxylic acid